Cargando…
Peptidomimetic blockade of MYB in acute myeloid leukemia
Aberrant gene expression is a hallmark of acute leukemias. MYB-driven transcriptional coactivation with CREB-binding protein (CBP)/P300 is required for acute lymphoblastic and myeloid leukemias, including refractory MLL-rearranged leukemias. Using structure-guided molecular design, we developed a pe...
Autores principales: | Ramaswamy, Kavitha, Forbes, Lauren, Minuesa, Gerard, Gindin, Tatyana, Brown, Fiona, Kharas, Michael G., Krivtsov, Andrei V., Armstrong, Scott A., Still, Eric, de Stanchina, Elisa, Knoechel, Birgit, Koche, Richard, Kentsis, Alex |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760651/ https://www.ncbi.nlm.nih.gov/pubmed/29317678 http://dx.doi.org/10.1038/s41467-017-02618-6 |
Ejemplares similares
-
Convergent organization of aberrant MYB complex controls oncogenic gene expression in acute myeloid leukemia
por: Takao, Sumiko, et al.
Publicado: (2021) -
Calculation of the Free Energy and Cooperativity of Protein Folding
por: Kentsis, Alex, et al.
Publicado: (2007) -
Therapeutic Re-Activation of Protein Phosphatase 2A in Acute Myeloid Leukemia
por: Ramaswamy, Kavitha, et al.
Publicado: (2015) -
Formation of Toxic Oligomeric Assemblies of RNA-binding Protein: Musashi in Alzheimer’s disease
por: Sengupta, Urmi, et al.
Publicado: (2018) -
Myb drives B-cell neoplasms and myeloid malignancies in vivo
por: Pieters, Tim, et al.
Publicado: (2022)